The immunohistochemistry method was used for all EndMT drivers. Briefly, lung tissue sections were deparaffinised in xylene and ethanol, respectively, followed by antigen retrieval performed at 110 °C for 15 min using target retrieval citrate buffer pH 6.0 (Dako S2369, Mulgrave, VIC, Australia) in a decloaking chamber (Biocare Medical, Pacheco, CA, USA). Primary antibodies were used to stain tissues for 60 min: mouse monoclonal TGF-β1 (1:2000, Abcam ab27969, Melbourne, VIC, Australia), polyclonal phospho-Smad2/Smad3 (pSmad-2/3, 1:100, ThermoFisher PA5-110155, Scoresby, VIC, Australia), mouse monoclonal Smad-7 (1:50, Santa Cruz Biotechnology sc-101152, Dallas, TX, USA), and rabbit monoclonal anti-β-catenin (1:100, Abcam ab32572, Melbourne, VIC, Australia), followed by secondary HRP rabbit/mouse antibodies (Dako K5007, Mulgrave, VIC, Australia). The DAB substrate (Dako K5007, Mulgrave, VIC, Australia) was added to make the protein markers visible, and hematoxylin (Australian Biostain P/L, Traralgon, Australia) was used to counterstain the nucleus. We have previously published using these techniques [4 (link),11 (link),12 (link),13 (link),14 (link),15 (link),16 (link),17 (link)].
Free full text: Click here